Clinical trial
A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries
Name
343-2022
Description
Single dose 600 mg gabapentin will be given preoperatively in anal surgeries
Trial arms
Trial start
2022-09-01
Estimated PCD
2022-12-31
Trial end
2022-12-31
Status
Completed
Phase
Early phase I
Treatment
Gabapentin
single preoperative dose of 600 mg gabapentin
Arms:
total analgesic consumption
Other names:
Gaptin 600 mg
Size
50
Primary endpoint
postoperative pain
first 12 hours postoperative
Eligibility criteria
Inclusion Criteria:
1. ASA physical status I or II
2. Aged from 18 to 65 years
3. Scheduled for anal surgeries at Minya University Hospital
Exclusion Criteria:
1. Presence of contraindications to neuraxial anesthesia
2. Presence of history of central nervous system or mental disorders, epilepsy, chronic pain, or drug abuse.
3. The use of neuropathic analgesic or antiepileptic drugs
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': '2 groups are included in the study', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'double-blinded study both participant and investigator are blind to the study drug', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 50, 'type': 'ACTUAL'}}
Updated at
2023-03-16
1 organization
1 product
2 indications
Organization
Minia UniversityProduct
GabapentinIndication
PainIndication
Postoperative